Corix Bioscience, Inc. (CXBS)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

Jun 11, 2025, 8:00 PM EDT

Corix Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2016	FY 2015
Period Ending	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Revenue	0.69	0.48
Revenue Growth (YoY)	43.78%	-
Gross Profit	0.69	0.48
Net Income	-4.43	-2.77
Gross Margin	100.00%	100.00%
Profit Margin	-638.63%	-573.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.